How do we encourage the development of new cell and gene therapies without compromising our ethics?

The Medicine Maker’s all-inclusive advent calendar…

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

Experts in the cell and gene therapy space are excited about things to come. After all, these are the pioneers of a burgeoning field of medicine.

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

What can the pharma industry do about the glass ceiling in women’s careers?

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.